1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
AHRQ PA-24-261 funds research to determine (1) whether and how breakthrough uses of AI systems affect patient safety in real clinical environments and (2) how AI systems can be safely implemented and used in healthcare delivery.
The R18 mechanism funds evaluation - this NOFO explicitly does not support development of new AI systems but rather the rigorous post-deployment evaluation of AI in live clinical settings, complementing AHRQ's broader digital healthcare portfolio. Topics include AI failure mode analysis, alert fatigue from clinical AI, AI-driven diagnostic safety, equity impacts of clinical AI, and human-AI team performance in care delivery.
Strong fit for health services researchers, patient safety researchers, and health systems studying AI deployment outcomes.
Get alerted about grants like this
Get emailed when new opportunities from “Agency for Healthcare Research and Quality (AHRQ)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: U.S. organizations including academic medical centers, universities, nonprofits, health systems, federal and state agencies, hospitals, and tribal organizations. Multiple PIs encouraged. AHRQ priority populations encouraged. Confirm the full requirements in the official notice before applying.
The current listing shows AHRQ R18 demonstration awards typically up to $400,000 direct costs per year for up to 3 years ($1.2M direct costs, ~$2M total with indirects). Multiple awards anticipated. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for AHRQ Examining the Impact of Artificial Intelligence AI on Healthcare Safety R18 PA-24-261 for Evaluating Deployed Clinical AI Systems are due December 8, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
AHRQ Examining the Impact of Artificial Intelligence AI on Healthcare Safety R18 PA-24-261 for Evaluating Deployed Clinical AI Systems is funded by Agency for Healthcare Research and Quality (AHRQ). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional) is sponsored by Agency for Healthcare Research and Quality (AHRQ) / National Institutes of Health (NIH). This funding opportunity invites applications that propose research projects testing promising digital healthcare interventions used at the point of care and aimed at improving the quality of healthcare services delivery. The R21/R33 mechanism provides support for initial developmental activities (R21) and expanded activities (R33).
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33) is sponsored by Agency for Healthcare Research and Quality (AHRQ). This funding opportunity invites applications for research projects that test promising digital healthcare interventions used at the point of care and aimed at improving the quality of healthcare services delivery. This could include point-of-care ultrasound diagnostics with digital integration.
PA-24-266 supports the development and implementation of digital healthcare solutions including AI/ML clinical decision support, generative AI for clinical workflows, smart point-of-care tools, and AI-based safety alerts that demonstrably improve healthcare quality, safety, and efficiency. The R21 phase funds early-stage feasibility and prototype work; the R33 phase funds translational scaling and clinical implementation. Standard receipt dates are February 16, June 16, and October 16, with the next round closing June 16, 2026, and a final cycle August 1, 2026. Strong fit for clinical AI teams, health systems, and digital health innovators with concrete deployment plans.
NCI ITCR Advanced Development U24 (RFA-CA-27-020) funds the maturation, enhancement, validation, and dissemination of emerging informatics technologies for cancer research and clinical care. Awards support AI/ML platforms ready to move beyond prototype, including deep learning cancer imaging tools, AI clinical decision support systems, multimodal cancer foundation models, AI-driven genomics pipelines, and digital pathology AI. Up to $600K direct costs per year for up to 5 years allows substantial software engineering, validation, and community adoption activities. Strong fit for established cancer informatics teams with mature AI prototypes ready for production deployment.
NCI ITCR Sustained Support U24 (RFA-CA-27-021) sustains widely-adopted cancer informatics technologies in production use by the cancer research community. Funds operational support, user experience improvement, security and accessibility hardening, and continued community engagement for mature AI/ML tools. Examples include cBioPortal, AI cancer imaging platforms, genomic data commons tools, and clinical informatics platforms. Up to $600K direct costs per year for up to 5 years. Strong fit for teams maintaining open-source cancer AI infrastructure with broad user communities.
EPA is offering $350K to $2.5M per award for HVAC upgrades, clean air shelters, and smoke readiness planning. Here is who qualifies and how to compete.
Read articleDespite NIH budget pressure, hundreds of millions in AI healthcare research grants remain active in 2026. Full breakdown of Bridge2AI, AHRQ patient safety, NSF/NIH Smart Health, BARDA, Gates Foundation, and Google.org — with eligibility, amounts, and current deadlines.
Read articleHow tribal nations and tribal college researchers can access EPA funding for water quality monitoring, PFAS contamination, and environmental capacity building.
Read article